Expression profiles of GPR21, GPR39, GPR135, and GPR153 orphan receptors in different cancers

Nucleosides Nucleotides Nucleic Acids. 2022;41(2):123-136. doi: 10.1080/15257770.2021.2002892. Epub 2022 Jan 12.

Abstract

Orphan receptors have unknown endogenous ligands, are expressed in different tissues, and participate in various diseases such as diabetes, hypertension and cancer. We studied the expression profiles of GPR21, GPR39, GPR135 and GPR153 orphan receptors in several tumour tissues. Cervical, breast, skin, prostate, and astrocytoma tissues were analysed for orphan receptor gene expression using Real time PCR analysis. GPR39 is over-expressed in cervical and prostate cancer tissues, and GPR21 and GPR135 receptors are significantly decreased in cervical, breast, skin, prostate, and astrocytoma tissues, when compared with healthy human fibroblasts. In conclusion, GPR21 and GPR135 receptor gene expression is reduced in cancerous tissues. GPR39 may have a role in the development and evolution of cervical and prostate cancer. These data suggest these receptors may be alternative molecules for new diagnostic approaches, and the design of novel therapeutics against oncological pathologies.

Keywords: GPR135; GPR153; GPR21; GPR39; Orphan receptors; cancer.

MeSH terms

  • Humans
  • Ligands
  • Male
  • Neoplasms* / genetics
  • Receptors, G-Protein-Coupled* / genetics

Substances

  • GPR135 protein, human
  • GPR21 protein, human
  • GPR39 protein, human
  • Gpr153 protein, human
  • Ligands
  • Receptors, G-Protein-Coupled